Seralutinib
N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino]ethyl]phenyl]-5-methylpyridine-3-carboxamide
Molecular Identity
Seralutinib
N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino]ethyl]phenyl]-5-methylpyridine-3-carboxamide
PubChem CID: 91663352
2D Structure
Properties
C27H27N5O3
Molecular Formula
469.50
Molecular Weight
g/mol
469.2114
Exact Mass
Da
3.7
XLogP
Drug-like (Lipinski: < 5)
98.3
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
7
H-Bond Acceptors
667
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Seralutinib1619931-27-9PK-10571Gb002Seralutinib [USAN]3P63ZTE3OYGB-002SERALUTINIB [INN]N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino]ethyl]phenyl]-5-methylpyridine-3-carboxamideUNII-3P63ZTE3OYPK10571SERALUTINIB [WHO-DD]structure 2a [WO2014110200A1]structure 2a (WO2014110200A1)N-(3-((1S)-1-((6-(3,4-DIMETHOXYPHENYL)-2-PYRAZINYL)AMINO)ETHYL)PHENYL)-5-METHYL-3-PYRIDINECARBOXAMIDE
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Seralutinib
Loading drug network...